Profs. Carlo Di Mario & Javier Escaned Discuss the DISRUPT CAD II Study at TCT19

Shockwave IVL
148 videos
After its presentation at TCT19 and simultaneous publication in Circulation: Cardiovascular Interventions, Profs. Carlo Di Mario & Javier Escaned discuss the key takeaways and implications on...
Read MoreAfter its presentation at TCT19 and simultaneous publication in Circulation: Cardiovascular Interventions, Profs. Carlo Di Mario & Javier Escaned discuss the key takeaways and implications on clinical practice for the DISRUPT CAD II Study, a post-market registry of coronary IVL in more patient and more centres than the first DISRUPT CAD I study.
Coronary IVL Important Safety Information: https://shockwavemedical.com/important-safety-information-coronary/
Downloadable Content Recommendations:
DISRUPT CAD II Data Sheet: http://shockwavemedical.com/wp-content/uploads/2020/05/CAD-II-Overview-Final-SPL-63348-Rev-B-10.18.pdf
DISRUPT CAD II Infographic: https://shockwavemedical.com/wp-content/uploads/2020/01/SPL-63393-CAD-II-Infographic.pdf
Read Full DISRUPT CAD II Study Publication: https://www.ahajournals.org/doi/full/10.1161/CIRCINTERVENTIONS.119.008434
About Shockwave IVL
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its unique MOA.
Prior to use, please reference the instructions for use and important safety information: ShockwaveC2ISI.com
ShockwaveIVL.com
Speakers
Carlo Di Mario is Professor of Cardiology at the University of Florence and Director of the Structural...
Carlo Di Mario is Professor of Cardiology at the University of Florence and Director of the Structural Interventional Cardiology Division of the University Hospital Careggi, Florence, Italy. Previous posts included 15 years as Professor of Clinical Cardiology at Imperial College of Sciences, Medicine & Technology, London and Consultant Cardiologist at the Royal Brompton Hospital. Despite his teaching, research and administrative commitments, he maintains an active clinical involvement performing more than 100 PCI per year with special interest in the treatment of calcified lesions, chronic total occlusions, bifurcations, and diffuse disease. He is a regular TAVI operator and certified implanter for the Medtronic Evolut R and Edwards Sapien 3 transcatheter aortic valves. He participated in more than 160 MitraClip implantations in London and Florence and has recently started direct annuloplasty with the CardioBand. Professor Di Mario pioneered the use of intracoronary Doppler, pressure measurement, intravascular ultrasound, optical coherence tomography, and near infrared spectroscopy. He was PI of the OPTICUS trial, failing to demonstrate superiority of IVUS guided stenting, and of the Lipid Rich Plaque study, due to report at TCT 2018. He was Principal Investigator of the DESTINI trial, using Doppler CRF to identify lesions in need of stenting, and of the CARESS in AMI trial, a large multicentre trial showing that patients who receive fibrinolytic therapy for ST-elevation myocardial infarction benefit from early angioplasty. This trial and a subsequent meta-analysis have led to a change in the European Society of Cardiology and AHA/ACC Guidelines for treatment of STEMI patients. He cooperated with Dr Davies to the validation of iFR to assess lesion severity and discriminate the contribution of individual lesions, and with Dr Lyon in the intracoronary delivery of SERCA-2 genes via adenoviral vectors in the CUPID2 trial.
Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He...
Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. A skilled interventionalist with over 30 years of experience, he regularly serves as live case operator and educationalist in global events like EuroPCR, TCT or the ESC Congress. He is author of over 500 PubMed indexed scientific articles (h-index 71) on topics that include complex PCI in multivessel disease (principal investigator of SYNTAX II study), left main and chronic total occlusions, and secondary revascularization. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Recent / ongoing trials as Co-PI include ADVISE, ADVISE II, DEFINE FLAIR and ABSORB II PHYSIOLOGY, being investigator also in ILUMIEN I and IV, COMBINE and other studies on coronary imaging. He is currently Deputy Editor for Interventional Cardiology of the European Heart Journal, as well as editor of two large textbooks: “Coronary Stenosis.Imaging, Structure and Physiology”, (co-editor Patrick Serruys) and “Physiological Assessment of Coronary Stenoses and the Microcirculation) (co-editor Justin Davies). Current or recent board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Some of his additional interests are philosophy, education and music.
Start a conversation